Hormone replacement therapy and Social avoidant behavior
Summary:
Social avoidant behavior is found among people with Hormone replacement therapy, especially for people who are female, 50-59 old.
The study analyzes which people have Social avoidant behavior with Hormone replacement therapy. It is created by eHealthMe based on reports of 13 people who have Hormone replacement therapy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Hormone replacement therapy?
Hormone replacement therapy is found to be associated with 10 drugs and 98 conditions by eHealthMe. Check the latest studies of Hormone replacement therapy.
What is Social avoidant behavior?
Social avoidant behavior is found to be associated with 476 drugs and 618 conditions by eHealthMe. Check the latest studies of Social avoidant behavior.
13 people who have Hormone Replacement Therapy and Social Avoidant Behavior are studied.

Gender of people who have Hormone Replacement Therapy and experienced Social Avoidant Behavior *:
- female: 84.62 %
- male: 15.38 %
Age of people who have Hormone Replacement Therapy and experienced Social Avoidant Behavior *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 16.67 %
- 50-59: 50.0 %
- 60+: 33.33 %
Common co-existing conditions for these people *:
- Depression: 5 people, 38.46%
- Stress And Anxiety: 3 people, 23.08%
- Pain: 3 people, 23.08%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 23.08%
- Migraine (headache): 2 people, 15.38%
- Incontinence (lack of moderation or self-control): 2 people, 15.38%
- High Blood Cholesterol: 2 people, 15.38%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 7.69%
- Menopause (end of monthly cycles in women): 1 person, 7.69%
- Hypersensitivity: 1 person, 7.69%
Common drugs taken by these people *:
- Premarin: 4 people, 30.77%
- Combipatch: 3 people, 23.08%
- Cymbalta: 3 people, 23.08%
- Nexium: 3 people, 23.08%
- Zopiclone: 2 people, 15.38%
- Promazine Hydrochloride: 2 people, 15.38%
- Cenestin: 2 people, 15.38%
- Citalopram Hydrobromide: 2 people, 15.38%
- Femring: 2 people, 15.38%
- Hyzaar: 2 people, 15.38%
Common symptoms for these people *:
- Depression: 8 people, 61.54%
- Dizziness: 6 people, 46.15%
- Fatigue (feeling of tiredness): 6 people, 46.15%
- Depressed Mood: 5 people, 38.46%
- Anger: 4 people, 30.77%
- Hyperhidrosis (abnormally increased sweating): 4 people, 30.77%
- Emotional Distress: 4 people, 30.77%
- Stress And Anxiety: 4 people, 30.77%
- Suicidal Ideation: 4 people, 30.77%
- Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight): 4 people, 30.77%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Social avoidant behavior?
- Check whether Social avoidant behavior is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Hormone replacement therapy (55,707 reports)
- Social avoidant behavior (7,385 reports)
All the drugs that are associated with Social avoidant behavior:
- Social avoidant behavior (476 drugs)
All the conditions that are associated with Social avoidant behavior:
- Social avoidant behavior (618 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Social avoidant behavior and Hormone replacement therapy, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Adcirca and Tracleer - 3 seconds ago
- Erection Increased and drugs of ingredients of zolpidem tartrate - 7 seconds ago
- Narcolepsy and Angioplasty - 14 seconds ago
- Systemic Lupus Erythematosus and Optic Atrophy - 16 seconds ago
- Could Bystolic cause Vision Blurred? - 18 seconds ago
- Donepezil and Hypokalemic Syndrome for Men aged 60+ - 21 seconds ago
- Donepezil and Hypokalaemic Syndrome for Men aged 60+ - 21 seconds ago
- Donepezil and Hypopotassemia for Men aged 60+ - 21 seconds ago
- Donepezil and Hypokalaemia for Men aged 60+ - 22 seconds ago
- Donepezil and Potassium - Low for Men aged 60+ - 22 seconds ago